Sai

Sai Life Sciences opens SSRL, a dedicated research facility for Schrödinger, at its Hyderabad R&D Campus

Retrieved on: 
Thursday, April 20, 2023

HYDERABAD, India, April 20, 2023 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growing global Contract Research, Development & Manufacturing Organisations (CRO-CDMO), today announced the opening of Sai Schrödinger Research Laboratories (SSRL) at its R&D campus in Hyderabad, India. The facility was inaugurated by Dr. Karen Akinsanya, President of R&D, Therapeutics at Schrödinger Inc., in the presence of members of the leadership team of Schrödinger and Sai Life Sciences.

Key Points: 
  • HYDERABAD, India, April 20, 2023 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growing global Contract Research, Development & Manufacturing Organisations (CRO-CDMO) , today announced the opening of Sai Schrödinger Research Laboratories (SSRL) at its R&D campus in Hyderabad, India.
  • The facility was inaugurated by Dr. Karen Akinsanya, President of R&D, Therapeutics at Schrödinger Inc., in the presence of members of the leadership team of Schrödinger and Sai Life Sciences.
  • Speaking at the occasion, Krishna Kanumuri, CEO & Managing Director, Sai Life Sciences, said, "Our collaboration with Schrödinger marks an exciting new start for us at Sai Life Sciences, with a dedicated facility to support multiple discovery programs.
  • Set up inside Sai Life Sciences' R&D campus in Genome Valley, SSRL is a dedicated facility for integrated discovery work streams including medicinal & synthetic chemistry , in vitro biology , and process chemistry .

Sai Life Sciences opens SSRL, a dedicated research facility for Schrödinger, at its Hyderabad R&D Campus

Retrieved on: 
Thursday, April 20, 2023

HYDERABAD, India, April 20, 2023 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growing global Contract Research, Development & Manufacturing Organisations (CRO-CDMO), today announced the opening of Sai Schrödinger Research Laboratories (SSRL) at its R&D campus in Hyderabad, India. The facility was inaugurated by Dr. Karen Akinsanya, President of R&D, Therapeutics at Schrödinger Inc., in the presence of members of the leadership team of Schrödinger and Sai Life Sciences.

Key Points: 
  • HYDERABAD, India, April 20, 2023 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growing global Contract Research, Development & Manufacturing Organisations (CRO-CDMO) , today announced the opening of Sai Schrödinger Research Laboratories (SSRL) at its R&D campus in Hyderabad, India.
  • The facility was inaugurated by Dr. Karen Akinsanya, President of R&D, Therapeutics at Schrödinger Inc., in the presence of members of the leadership team of Schrödinger and Sai Life Sciences.
  • Speaking at the occasion, Krishna Kanumuri, CEO & Managing Director, Sai Life Sciences, said, "Our collaboration with Schrödinger marks an exciting new start for us at Sai Life Sciences, with a dedicated facility to support multiple discovery programs.
  • Set up inside Sai Life Sciences' R&D campus in Genome Valley, SSRL is a dedicated facility for integrated discovery work streams including medicinal & synthetic chemistry , in vitro biology , and process chemistry .

AerSale Announces Appointment of Andrew Levy to its Board of Directors and Planned Retirement of Existing Members.

Retrieved on: 
Wednesday, April 19, 2023

AerSale Corporation (Nasdaq: ASLE) (the “Company”) announced today that Andrew Levy, Founder, Chairman and CEO of Avelo Airlines was appointed to the Company’s board of directors on April 15, 2023.

Key Points: 
  • AerSale Corporation (Nasdaq: ASLE) (the “Company”) announced today that Andrew Levy, Founder, Chairman and CEO of Avelo Airlines was appointed to the Company’s board of directors on April 15, 2023.
  • Prior to launching Avelo in April 2021, Mr. Levy was a Co-Founder and President at Allegiant Air and CFO at United Airlines.
  • The appointment of Mr. Levy to the AerSale Board of Directors will temporarily increase the size of the Company’s board to 11 members through the 2023 annual stockholders meeting.
  • We would like to thank all three of our exiting board members and wish them all the best for the future.”

Absci Deepens Scientific Advisory Board to Accelerate Generative AI Drug Creation

Retrieved on: 
Wednesday, February 8, 2023

VANCOUVER, Wash. and NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the expansion of its Scientific Advisory Board with three world-class scientific leaders: Victor Greiff, Ph.D., Timothy Lu, MD, Ph.D., and Hubert Truebel, MD, Ph.D., MBA.

Key Points: 
  • VANCOUVER, Wash. and NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the expansion of its Scientific Advisory Board with three world-class scientific leaders: Victor Greiff, Ph.D., Timothy Lu, MD, Ph.D., and Hubert Truebel, MD, Ph.D., MBA.
  • These renowned leaders in AI drug design, synthetic biology, and translational medicine, respectively, will play a pivotal role in helping Absci continue to pioneer AI drug creation in its mission to create better biologics for patients, faster.
  • “In silico drug design requires vast amounts of high-quality wet lab datasets to effectively build and train generative AI models.
  • “Absci is harnessing generative AI to pioneer the next frontier of antibody drug discovery to deliver better drugs to patients faster,” said Dr. Lu.

Sai Life Sciences inks strategic agreement to set up Schrödinger's first dedicated offshore Research Laboratories in India

Retrieved on: 
Tuesday, January 10, 2023

HYDERABAD, India, Jan. 10, 2023 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growing global Contract Research, Development & Manufacturing Organisations (CRO-CDMO), today announced that it has entered a 5-year strategic agreement with Schrödinger, whose physics-based computational platform is transforming the way therapeutics and materials are discovered, to set up the Sai Schrödinger Research Laboratories (SSRL) in Hyderabad, India.

Key Points: 
  • HYDERABAD, India, Jan. 10, 2023 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growing global Contract Research, Development & Manufacturing Organisations (CRO-CDMO), today announced that it has entered a 5-year strategic agreement with Schrödinger, whose physics-based computational platform is transforming the way therapeutics and materials are discovered, to set up the Sai Schrödinger Research Laboratories (SSRL) in Hyderabad, India.
  • Being built inside Sai Life Sciences' R&D campus in genome valley, Hyderabad, SSRL will be a dedicated facility for integrated discovery work streams including medicinal & synthetic chemistry , in vitro biology , and process chemistry .
  • It will access other Sai capabilities such as in vitro ADME and in vivo PK as needed.
  • Making the announcement, Krishna Kanumuri, CEO & Managing Director, Sai Life Sciences, said, "We're truly delighted that Schrödinger has decided to partner with Sai Life Sciences to set-up their first offshore research laboratories.

Sai Life Sciences inks strategic agreement to set up Schrödinger's first dedicated offshore Research Laboratories in India

Retrieved on: 
Tuesday, January 10, 2023

HYDERABAD, India, Jan. 10, 2023 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growing global Contract Research, Development & Manufacturing Organisations (CRO-CDMO), today announced that it has entered a 5-year strategic agreement with Schrödinger, whose physics-based computational platform is transforming the way therapeutics and materials are discovered, to set up the Sai Schrödinger Research Laboratories (SSRL) in Hyderabad, India.

Key Points: 
  • HYDERABAD, India, Jan. 10, 2023 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growing global Contract Research, Development & Manufacturing Organisations (CRO-CDMO), today announced that it has entered a 5-year strategic agreement with Schrödinger, whose physics-based computational platform is transforming the way therapeutics and materials are discovered, to set up the Sai Schrödinger Research Laboratories (SSRL) in Hyderabad, India.
  • Being built inside Sai Life Sciences' R&D campus in genome valley, Hyderabad, SSRL will be a dedicated facility for integrated discovery work streams including medicinal & synthetic chemistry , in vitro biology , and process chemistry .
  • It will access other Sai capabilities such as in vitro ADME and in vivo PK as needed.
  • Making the announcement, Krishna Kanumuri, CEO & Managing Director, Sai Life Sciences, said, "We're truly delighted that Schrödinger has decided to partner with Sai Life Sciences to set-up their first offshore research laboratories.

Daily Media Studio Announces Top 10 Asian Restaurants in NYC to Visit in 2022

Retrieved on: 
Tuesday, February 1, 2022

Since the Year of the Tiger involves big changes, why not change up your dining routine by trying out one or all of the following authentic Asian restaurants?New York City news channel Daily Media Studio is recommending the top 10 Asian Fusion Restaurants must try.

Key Points: 
  • Since the Year of the Tiger involves big changes, why not change up your dining routine by trying out one or all of the following authentic Asian restaurants?New York City news channel Daily Media Studio is recommending the top 10 Asian Fusion Restaurants must try.
  • Tao DowntownWith several locations across the country, Tao DT encompasses Asian culture in a unique way.
  • With an extraordinary Buddha sculpture sitting atop a grandiose staircase, the impressive dining atmosphere below is a mixture of Asian and American-mainstream culture.
  • The restaurant's interior replicates a traditional, Chinese setting with original photography from the initial Shen Yu meat shop.

New Leadership Redefines and Expands UTime Fitness

Retrieved on: 
Thursday, October 28, 2021

HONG KONG, Oct. 28, 2021 /PRNewswire/ -- In the middle of COVID-related upheavals in the fitness industry, UTime Fitness has evolved with a redefinition of fitness management, UK expansion, and a flexible, integrated new product.

Key Points: 
  • HONG KONG, Oct. 28, 2021 /PRNewswire/ -- In the middle of COVID-related upheavals in the fitness industry, UTime Fitness has evolved with a redefinition of fitness management, UK expansion, and a flexible, integrated new product.
  • After his latest successful fitness franchise leadership role, the brand is now led by long-time fitness leader Rey Bolivar the newly appointed CEO and Managing Partner of UTime Fitness.
  • UTime Fitness is redefining the fitness industry by providing a truly seamless fitness experience.
  • UTime Fitness is a modular fitness franchise offering a fully integrated fitness experience with flexible and hybrid memberships driven by results-based fitness and wellness solutions available on location, on demand, and on the go.

The First ESG Report in the Digital Field Leads the Low-Carbon Era

Retrieved on: 
Tuesday, August 3, 2021

In this context, on July 20th, SAI technology ESG report (2021) was released.

Key Points: 
  • In this context, on July 20th, SAI technology ESG report (2021) was released.
  • As the first ESG report in the industry, the research achievements and innovative measures of SAI Technology are advanced and cutting-edge.
  • SAI released the first ESG report, leading the industry to make green transformation
    On July 20th, SAI Technology released the 2021 ESG Report.
  • The dual carbon target is the theme of the current era and a topic that must be tackled.

Leidos Announces Leadership Changes as Part of Ongoing Optimization Efforts

Retrieved on: 
Thursday, July 1, 2021

RESTON, Va., July 1, 2021 /PRNewswire/ -- Leidos (NYSE:LDOS), a FORTUNE 500 science and technology leader, today announced leadership changes as part of ongoing efforts tooptimize internal processes and develop talent.

Key Points: 
  • RESTON, Va., July 1, 2021 /PRNewswire/ -- Leidos (NYSE:LDOS), a FORTUNE 500 science and technology leader, today announced leadership changes as part of ongoing efforts tooptimize internal processes and develop talent.
  • Previously, Engola served as deputy group president for Leidos' former Defense and Intelligence Group, as well as in various roles within Lockheed Martin Space Systems.
  • George Reiter,senior vice president for Leidos' Human Resources Centers of Excellence,will act as CHRO while a thoughtful search for a replacement is conducted.
  • "These leaders have demonstrated their commitment to the Leidos team and expertise in multiple fields," said Roger Krone, Leidos chairman and CEO.